BACKGROUND: Asparaginase (ASNase) is an essential component of most treatment protocols for childhood acute lymphoblastic leukemia (ALL). Although increased asparagine synthetase (ASNS) expression may contribute to ASNase resistance, there is conflicting data from patient samples with regard to correlation between ASNS mRNA content and ASNase sensitivity. PROCEDURE: Both T-cell and B-cell derived ALL cell lines were treated with ASNase and then monitored for cell proliferation, cell death, and ASNS mRNA and protein expression. RESULTS: Despite elevated ASNS mRNA following ASNase treatment, different ALL cell lines varied widely in translation to ASNS protein. Although ASNS mRNA levels did not consistently reflect ASNase sensitivity, there was an inverse correlation between ASNS protein and ASNase-induced cell death. Expression of ASNS in an ASNase-sensitive cell line resulted in enhanced ASNase resistance, and conversely, siRNA-mediated inhibition of ASNS expression promoted increased drug sensitivity. CONCLUSIONS: These observations provide an explanation for the ASNase sensitivity of ALL cells and demonstrate the importance of measuring ASNS protein rather than mRNA in predicting ASNase responsiveness. (c) 2007 Wiley-Liss, Inc.
BACKGROUND: Asparaginase (ASNase) is an essential component of most treatment protocols for childhood acute lymphoblastic leukemia (ALL). Although increased asparagine synthetase (ASNS) expression may contribute to ASNase resistance, there is conflicting data from patient samples with regard to correlation between ASNS mRNA content and ASNase sensitivity. PROCEDURE: Both T-cell and B-cell derived ALL cell lines were treated with ASNase and then monitored for cell proliferation, cell death, and ASNS mRNA and protein expression. RESULTS: Despite elevated ASNS mRNA following ASNase treatment, different ALL cell lines varied widely in translation to ASNS protein. Although ASNS mRNA levels did not consistently reflect ASNase sensitivity, there was an inverse correlation between ASNS protein and ASNase-induced cell death. Expression of ASNS in an ASNase-sensitive cell line resulted in enhanced ASNase resistance, and conversely, siRNA-mediated inhibition of ASNS expression promoted increased drug sensitivity. CONCLUSIONS: These observations provide an explanation for the ASNase sensitivity of ALL cells and demonstrate the importance of measuring ASNS protein rather than mRNA in predicting ASNase responsiveness. (c) 2007 Wiley-Liss, Inc.
Authors: S-H Chen; W Yang; Y Fan; G Stocco; K R Crews; J J Yang; S W Paugh; C-H Pui; W E Evans; M V Relling Journal: Leukemia Date: 2010-11-12 Impact factor: 11.528
Authors: Wai Kin Chan; Philip L Lorenzi; Andriy Anishkin; Preeti Purwaha; David M Rogers; Sergei Sukharev; Susan B Rempe; John N Weinstein Journal: Blood Date: 2014-03-21 Impact factor: 22.113
Authors: Jean Hugues Parmentier; Maristella Maggi; Erika Tarasco; Claudia Scotti; Vassilios I Avramis; Steven D Mittelman Journal: Leuk Res Date: 2015-04-22 Impact factor: 3.156
Authors: Stephanie J Sacharow; Elizabeth E Dudenhausen; Carrie L Lomelino; Lance Rodan; Christelle Moufawad El Achkar; Heather E Olson; Casie A Genetti; Pankaj B Agrawal; Robert McKenna; Michael S Kilberg Journal: Mol Genet Metab Date: 2017-12-20 Impact factor: 4.797
Authors: Stela S Palii; Beth O Van Emburgh; Umesh T Sankpal; Kevin D Brown; Keith D Robertson Journal: Mol Cell Biol Date: 2007-11-08 Impact factor: 4.272
Authors: Philip L Lorenzi; Jenny Llamas; Michele Gunsior; Laurent Ozbun; William C Reinhold; Sudhir Varma; Helen Ji; Hijoo Kim; Amy A Hutchinson; Elise C Kohn; Paul K Goldsmith; Michael J Birrer; John N Weinstein Journal: Mol Cancer Ther Date: 2008-10 Impact factor: 6.261
Authors: Piyawan Bunpo; Allison Dudley; Judy K Cundiff; Douglas R Cavener; Ronald C Wek; Tracy G Anthony Journal: J Biol Chem Date: 2009-09-25 Impact factor: 5.157